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LysosomeIn cardiomyocytes subjected to stress, autophagy activation is a critical survival mechanism that preserves cellu-
lar energy status while degrading damaged proteins and organelles. However, little is known about the mecha-
nisms that govern this autophagic response. Cellular repressor of E1A genes (CREG1) is an evolutionarily
conserved lysosomal protein, and an important new factor in regulating tissue homeostasis that has been
shown to antagonize injury of tissues or cells. In the present study, we aimed to investigate the regulatory role
of CREG1 in cardiac autophagy, and to clarify autophagy activation mechanisms. First, we generated a CREG1
haploinsufﬁciency (Creg1+/−)mousemodel, and identiﬁed that CREG1deﬁciency aggravatesmyocardialﬁbrosis
in response to aging or angiotensin II (Ang II). Conversely, exogenous infusion of recombinant CREG1 protein
completely reversed cardiac damage. CREG1deﬁciency inCreg1+/−mouseheart showed amarked accumulation
of autophagosome that acquired LC3II and beclin-1, and a decrease in autophagic ﬂux clearance as indicated by
upregulating the level of p62. Inversely, restoration of CREG1 activates cardiac autophagy. Furthermore, chloro-
quine, an inhibitor of lysosomal acidiﬁcation, was used to conﬁrm that CREG1 protected the heart tissue against
Ang II-induced ﬁbrosis by activating autophagy. Using adenoviral infection of primary cardiomyocytes, overex-
pression of CREG1 with concurrent resveratrol treatment signiﬁcantly increased autophagy, while silencing
CREG1 blocked the resveratrol-induced autophagy. These results suggest that CREG1-induced autophagy is
required to maintain heart function in the face of stress-induced myocardiac damage. Both in vitro and in vivo
studies identiﬁed that CREG1 deﬁciency inﬂuenced the maturation of lysosomes and reduced the expression of
Rab7,whichmight be involved in CREG1-induced cardiomyocyte autophagy. Theseﬁndings suggest that autoph-
agy activation via CREG1 may be a viable therapeutic strategy for improving cardiac performance under patho-
logic conditions. This article is part of a Special Issue entitled: Autophagy and protein quality control in
cardiometabolic diseases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Myocardial ﬁbrosis is a critical aspect of cardiac remodeling follow-
ing myocardial infarction, hypertension and other cardiovascular
diseases [1,2]. This process is initially an adaptive response to maintain
cardiac function by reducing stress on the walls of the heart and
decreasing energy expenditure; impairing this adaptive mechanism
leads to heart failure [3,4]. A more complete understanding of how the
heart senses and responds to stress would allow for the development
of more effective therapeutic strategies to treat myocardial ﬁbrosis,
with the ultimate goal of eradicating the problem entirely through
prevention as well as treatment.y and protein quality control in
henyang Northern Hospital, 83
56123; fax: +86 24 23922184.Autophagy is a lysosome-mediated catabolic process in which se-
nescent or damaged proteins and organelles are sequestered by double
membrane-limited vesicles called autophagosomes, and then degraded
by lysosomes [5]. Accumulating evidence attests to a pro-survival role
for autophagy when cells are under stress by facilitating the removal
of damaged proteins and organelles, and by recycling basic building
blocks that can be used for energy generation and targeted macromo-
lecular synthesis to shore up cellular defenses [6,7]. Recently, autophagy
was found to be upregulated during stress conditions such as heart fail-
ure, pressure overload, nutrient starvation, ischemia-reperfusion injury,
and proteotoxic disease [8–10]. As a housekeeping process, autophagy is
critical for the normal structure and function of the heart. Dysfunctional
autophagy has been implicated in cardiac diseases, with particularly
strong evidence in the case of cardiac impairment, which is thought to
be a result of imbalance between autophagosome production and
clearance [11]. As an important organelle involved in autophagosome
clearance, lysosome function is an attractive target for therapeutic
intervention to treat or prevent heart disease. However, up to now,
our understanding of the molecular mechanisms contributing to the
Table 1
RT-PCR primer sequences.
Rab7-F 5′-AAGCCACAATAGGAGCGGAC -3′
Rab7-R 5′-AGACTGGAACCGTTCTTGACC-3′
mCREG1-F 5′-TGTCGGGAACTGTGACCAAG-3′
mCREG1-R 5′-CTTTAGTTGTTGAAATCTGTG-3′
hCREG1-F 5′-GGCGTGCCCTATTTCTACCTG-3′
hCREG1-R 5′-TTTCTTGCAGAAGTTGGTCTGT-3′
GAPDH-F 5′-TCAACGACCCCTTCATTGAC-3′
GAPDH-R 5′-ATGCAGGGATGATGTTCTGG-3′
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and stress remains rudimentary.
The cellular repressor of E1A-stimulated genes (CREG1) is a new,
important glycoprotein that regulates tissue homeostasis. CREG1 has
been shown to antagonize tissue or cellular injury [12,13]. Despite
potentially signiﬁcant roles of CREG1 remaining unclear, Xu et al. [14]
reported that CREG1 expression is decreased during biomechanical
stress in the heart, and function to attenuate cardiac hypertrophy.
Recent studies [15–18] showed that CREG1 is a lysosomal protein that
undergoes proteolytic maturation by lysosomal cysteine proteases in
the course of its biosynthesis. CREG1 contains three mannose 6-
phosphate (M6P) markers, and depends on interactions with M6P
receptors for efﬁcient delivery to lysosomes, which is implicated in the
regulation of lysosomal functions. Therefore, in the present study, we
aimed to investigate the role of CREG1 in cardiac stress mediated by
angiotensin II (Ang II) and to clarify its molecular mechanisms.
2. Methods
2.1. Animals
Male heterozygous Creg1+/−mice were generated and bred at the
Southern model animal center as described previously [19]. Age-
matched male transgenic-negative wild-type (Creg1+/+) littermates
were used as controls. All experiments were approved by the Animal
Ethical Committee of Shenyang General Hospital and conducted in
accordance with existing guidelines on the care and use of laboratory
animals. Animal model surgery and echocardiography and hemody-
namic analyses were performed as previously described [20].
2.2. Mouse experiments
Two-month-old Creg1+/− and Creg1+/+ mice were subjected to an
infusion of Ang II (1.5 mg/kg · day) for 14 days. In another series of ex-
periments (reversal experiment), 2-month-old male Creg1+/− mice
were subjected to an infusion of Ang II for 14 days, while being treated
with recombinant CREG1 protein (0.03/0.06/0.3 mg/kg · day) or
with chloroquine (5 or 10 mg/kg · day) for 14 days (starting from
day 1 and continuing until day 14). Chloroquine (N4-(7-chloro-4-
quinolinyl)-N1,N1-dimethyl-1,4-pentanediamine diphosphate salt)
and resveratrol were purchased from Sigma-Aldrich (Poole, United
Kingdom).
2.3. Immunohistochemistry
Hearts were isolated and ﬁxed with buffered 3.7% formalin for
24 hours. Thereafter, tissue sections were dehydrated and embedded
in parafﬁn. Another slicewas embedded in tissue-tic, placed on a carton
disk put on a Petri dish and immediately, but slowly, frozen above liquid
nitrogen. For immunohistochemistry, 3-μm-thick sectionswere cut on a
microtome and mounted on slides. Hearts were cut at the midpapillary
level.
2.4. Masson’s trichrome staining
To measure ﬁbrosis, Masson’s trichrome staining was performed on
parafﬁn sections for all experimental animals. Whole stained sections
were scanned (Nanozoomer 2.0-HT, Hamamatsu, Japan) and a ﬁbrosis
score for the entire section was calculated using 20× magniﬁcation for
mice (ScanScope, Aperio Technologies, Vista, CA, USA).
2.5. Transmission Electron Microscopy
Transmission electron microscopy (TEM) of perfusion-ﬁxed myo-
cardium was performed as previously described [9]. Autophagosomes
or autolysosomes were identiﬁed by the characteristic structure of adouble- or multi-lamellar smooth membrane completely surround-
ing compressed mitochondria, or membrane-bound electron-dense
material.
2.6. Assessing autophagic ﬂux in heart
Micewere delivered Ang II (Sigma), His-tagged human recombinant
CREG1 protein (Abcam, CA, USA), or chloroquine (5 or 10 mg/kg · day)
using osmotic pumps (Alzet Model 1004, PA, US), PBS as vehicle con-
trol. The mice were euthanized and ventricular myocardium was
sampled for Western blot analyses of LC3II/I levels, Beclin 1 and
p62 expression [8].
2.7. RT-PCR
Total RNA was isolated using TRIzol Reagent (Invitrogen, CA, USA).
Reverse transcription was performed at 50 °C for 50 min, and then
85 °C for 5min using the SuperScript III First-Strand Synthesis SuperMix
for RT-PCR kit (Invitrogen, CA, USA). RT-PCR was performed on a Bio-
Rad T100 PCR System (primer sequences are shown in Table 1).
2.8. Western blotting
Proteinwas extracted from cardiac tissue and cardiomyocytes. Equal
amounts of protein (50 μg) were separated by SDS–PAGE (150 V, 1 h)
and transferred into a polyvinylidene diﬂuoride membrane. After
blocking, blots were probed with anti-Beclin 1, anti-LC3, anti-p62 or
anti-β-actin antibody (Cell Signaling, PA, USA) at 4 °C overnight. After
washing, the membrane was incubated with horseradish peroxidase
(HRP)-conjugatedAfﬁniPure rabbit anti-goat IgG (H+L) (Thermo Scien-
tiﬁc, PA, USA) for 1 hour. After washing again, immunological complexes
were detected using the SuperSignal West Pico Chemiluminescent
Substrate (Thermo Scientiﬁc, PA, USA).
2.9. Confocal microscopy
After removing the culture media, the samples were ﬁxed with 3.7%
formaldehyde at 37 °C. The samples were permeabilized with 1% Triton
X-100 in PBS-T (Triton X-100: phosphate buffered saline 1:100, volume
ratio) for 15 min. The samples were then incubated with Alexa Fluor
555 Phalloidin (1:40, Invitrogen) for 20 min. The cells were stained
with the chromatin dye, DAPI (300 nmol/L, Invitrogen), for 5 min. Im-
ages were obtained using an Olympus confocal microscope (Olympus,
Japan).
2.10. Primary culture of mouse cardiomyocytes
Primary cardiac myocytes (CMs) were isolated, puriﬁed and main-
tained in medium 199 (M199) supplemented with 10% fetal bovine
serum at 37 °C in an atmosphere of 5% CO2 and 95% air. The phenotype
of primary cardiomyocytes was conﬁrmed morphologically and by
positive immunoﬂuorescence staining of anti-actinin. All experiments
with cells were performed with subcultures 4–10 after cloning. For
autophagic studies, early passage CMs (passage 2–3) were plated in
Fig. 1. Creg1+/−mice are more susceptible to cardiac ﬁbrosis with aging. A: Western blot of CREG1 expression in hearts from 2-month-old and 6-month-old Creg1+/−mice and age-
matched Creg1+/+controls; β-actin was probed for loading control. B: Densitometry of immunoblots showing quantiﬁcation of changes in CREG1 expression. C: Real-time PCR for
CREG1 expression in hearts from 2-month-old and 6-month-old Creg1+/− mice and age-matched Creg1+/+ controls; GAPDH was probed for loading control. D: Densitometry of
bands showing the semi-quantiﬁcation of changes in CREG1. E:Masson trichrome stains showed increasedmyocardial ﬁbrosis in hearts from 2- or 6-month-old Creg1+/−mice compared
with age-matched Creg1+/+ controls. F and G: Western blot of collagen I and III expression in hearts from 6-month-old Creg1+/− mice and age-matched Creg1+/+ controls; β-actin
was probed for loading control. H: Sectionswere immunostained for CREG1 (green) and collagen I (red) in hearts from 6-month-old Creg1+/−mice and age-matched Creg1+/+ controls;
bars = 100 μm. **p b 0.01 and ***p b 0.001.
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treatment in 10% FCS for 24 hours.
2.11. Adenoviral infection
Adenoviral GFP and CREG1 vectors were created as described
previously [17]. These replication-deﬁcient vectors were propagated
in AD293 cells using Dulbecco’s modiﬁed eagle’s medium (DMEM)
supplemented with 10% (v/v) FBS. The CMs were infected with DMEM
containing 1 × 108 AdGFP or AdCREG adenovirus particles/mL for 2 con-
secutive days. The expression of CREG1was assessed by immunoblotting.
2.12. Generation of CREG1 and Rab7 knockdown cells
CREG1 and Rab7 RNAi vectors (Abcam, CA, USA) were transfected in
primary cardiomyocytes using FuGene 6 (Roche, Mannheim, Germany)
for immunoﬂuorescencemicroscopy, or forWestern blotting, according
to instructions given by the manufacturer.
2.13. Statistical analysis
Data are expressed asmean± SD. All data were analyzed using SPSS
13.0 statistical software (SPSS, Chicago, IL, USA). Differences between
two groups were compared using an unpaired Student’s t-test. Differ-
ences among three or more groups were compared using a one-way
analysis of variance. Statistical signiﬁcance was deﬁned as p b 0.05
(two-tailed).
3. Results
3.1. Creg1+/−mice are more susceptible to cardiac damage in response to
aging or Ang II stimulation
Western blotting showed that CREG1 expression was signiﬁcantly
decreased in 2-month-old or 6-month-old Creg1+/− mouse heart
compared with age-matched Creg1+/+ mice (Fig. 1A and B). RT-PCR
analysis showed that there was no signiﬁcant difference in mRNA
levels in the 2-month-old Creg1+/−mouse heart compared with agedFig. 2. Creg1+/−mice are more susceptible to myocardial ﬁbrosis in response to Ang II stimula
(1.5 mg/kg · day) for 14 days. A: Masson trichrome stain showed that myocardial ﬁbrosis sign
mice 14 days after Ang II treated. B and C: Western blot of CREG1 expression in 2-month-old
7 days. β-Actin was probed for loading control. Densitometry of immunoblots showing quanti
for CREG1mRNA expression after 0, 3 and 7 days of treatment by Ang II stimulation in 2-month
control; bars = 100 μm. ***p b 0.001.Creg1+/+ mouse heart; however, in 6-month-old Creg1+/− mouse
hearts, CREG1 expression in mRNA levels were slightly downregulated
(Fig. 1C and D). Masson trichrome staining revealed the low level of in-
terstitial ﬁbrosis in 2-month-old Creg1+/−mice hearts; however, with
increasing age (from 2 to 6 months of age), ﬁbrosis-positive labeling
was strongly increased in 6-month-old Creg1+/− hearts (Fig. 1E).
Meanwhile, immunoﬂuorescence staining and Western blot analysis
showed that collagen I and III levels were signiﬁcantly increased in
6-month-old Creg1+/− mouse hearts compared with age-matched
Creg1+/+ controls (Fig. 1F to H). These data suggest that CREG1 de-
ﬁciency plays a critical role in the emergence of myocardial ﬁbrosis.
To further conﬁrm these ﬁndings, we established an Ang II-induced
myocardial ﬁbrosis model in 2-month-old Creg1+/− and Creg1+/+
mice. Fourteen days after Ang II treatment, we observed cardiac damage
results similar to those obtained with age increase using this model
(Fig. 2A). More interestingly, three days after Ang II treatment, there
was a rapid and dramatic downregulation of CREG1 both in protein
(Fig. 2B and 2C) and mRNA levels (Fig. 2D and E) in Creg1+/− mouse
hearts and in Creg1+/+ mouse hearts. It is implied that deﬁciency
of CREG1 expression was more susceptible to induce the myocardial
ﬁbrosis.
3.2. Deﬁciency of CREG1 impaired autophagy function in hearts of
Creg1+/− mice
Because CREG1 is a lysosome-related protein [18], we hypothesized
that lack of CREG1 may be involved in the lysosome–autophagy
function, which plays an important role in preventing heart disease.
Western blot analysis identiﬁed that the ratio of LC3II/I and the level
of Beclin-1, both indicators of macroautophagy and CMA autophagy,
were increased in cardiomyocytes of Creg1+/− mice compared with
that in Creg1+/+ controls (Fig. 3A and B). This was accompanied by in-
creased accumulation of LC3-positive vesicles on immunoﬂuorescence
analysis (Fig. 3C). Meanwhile, p62, an adapter protein that indicates
clearance of autophagosomes, was investigated to accumulate signiﬁ-
cantly in Creg1+/− cardiomyocytes compared with that in Creg1+/+
control (Fig. 3A and B). Moreover, Western blot analysis identiﬁed
that the ratio of LC3II/I and the expression of Beclin-1 and p62 weretion. Two-month-old Creg1+/− and Creg1+/+ mice were subjected to an infusion of Ang II
iﬁcantly increased in 2-month-old Creg1+/−mice heart compared with that in Creg1+/+
Creg1+/−mice heart and age-matched Creg1+/+ mice after Ang II treatment for 0, 3 and
ﬁcation of changes in CREG1 expression. D and E: Real-time PCR and semi-quantiﬁcation
-old Creg1+/−mice heart and age-matched Creg1+/+mice, GAPDHwas probed for loading
Fig. 3. Deﬁciency of CREG1 results in autophagosome accumulation and impairs autophagic ﬂux clearance in Creg1+/−mice heart with and without Ang II treatment. A: sections were
immunostained for LC3 (green) and actinin (red) in 6-month-old Creg1+/−mice hearts and age-matched Creg1+/+mice; yellow arrows show LC3 accumulation. Bars= 100 μm. B: Rep-
resentative image ofWestern blot analyses of LC3II/I, Beclin 1 and p62 in 6-month-old Creg1+/−mice heart and age-matched Creg1+/+mice. C: A summary of densitometry data
for LC3II/I, Beclin1 andp62,β-actinwasprobed for loading control. D to F: Representative images ofWestern blot analyses of LC3, Beclin 1 and p62, and a summaryof densitometry data in
2-month-old Creg1+/−mice hearts and age-matched Creg1+/+micewith or without Ang II stimulation, β-actinwas probed for loading control. G: Sectionswere immunostained for LC3
(green) and p62 (red) in 2-month-old Creg1+/−mice hearts and age-matched Creg1+/+micewith orwithout Ang II stimulation; yellow arrows show LC3 accumulation. Bars= 100 μm.
#p b 0.05, **p b 0.01 and ***p b 0.001.
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Creg1+/+ controls after three days of Ang II treatment (Fig. 3D and E).
Furthermore, immunoﬂuorescent staining revealed that both the level
of p62 and LC3 were markedly enhanced in Creg1+/− hearts compared
to Creg1+/+ controls (Fig. 3F). These data suggest that autophagic ﬂux
clearance, but not the formation of early autophagosomes, was im-
paired because of the deﬁciency of CREG1, which might be related to
the occurrence ofmyocardium impairment under chronic, severe stress.3.3. Recombinant CREG1 protein infusion rescues Ang II-inducedmyocardial
ﬁbrosis via activation of autophagy in Creg1+/−mice
To further evaluate the effect of CREG1 on myocardial ﬁbrosis and to
determine the potential therapeutic value of increased CREG1 function,
we used osmotic pumps (Alzet Model 1004, PA, US) to deliver His-
tagged recombinant human CREG1 protein (0.03/0.06/0.3mg/kg · day;
Abcam, CA, USA) and Ang II (1.5mg/kg · day) concurrent into the
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recombinant CREG1 protein was detected in the serum of treated mice
from 3 days up to 14 days. Additionally, Western blotting using anti-
His antibody identiﬁed the recombinant CREG1 protein was delivered
in treated myocardial cells (data not shown). Remarkably, HE and
Masson staining showed that Ang II-induced myocardial ﬁbrosis was
rescued completely in a dose-dependent manner upon treatment with
recombinant CREG1 (Fig. 4A). We further monitored autophagic ﬂux
after recombinant CREG1 treatment for 3 days byWestern blot analysis.
LC3II/I and Beclin-1markedly increased, while the level of p62markedly
decreased in Creg1+/− hearts with recombinant CREG1 protein treat-
ment compared with those without CREG1 protein treatment (Fig. 4B
and C). To validate whether CREG1 antagonized myocardial ﬁbrosis by
modulation of autophagic activity, we blocked autophagic ﬂux using dif-
ferent concentrations of chloroquine (5 or 10 mg/kg · day), a lysosome
inhibitor, in Ang II-stressed Creg1+/− hearts with recombinant CREG1
protein treatment. LC3II/I, Beclin-1 and p62 levels were detected to
increase in chloroquine-treated groups in dose-dependent manner
(Fig. 4D and E), accompanied by further exaggeration of the ﬁbrosis
response, similar to what we saw with CREG1 deﬁciency (Fig. 4F). It
is suggested that recombinant CREG1 protein treatment protected
mice hearts against myocardial ﬁbrosis accompanied by activation of
autophagy.
3.4. Deﬁciency of CREG1 impairs the maturation of lysosome associated
with reduction of Rab7
Excessive accumulation of autophagic vacuoles resulting from im-
pairment of autophagosome–lysosome fusion or lysosome dysfunction
[23]. Therefore, we further investigated the impact of CREG1 deﬁciency
on the biogenesis of lysosome in the heart. In contrast to Creg1+/+mice,
lysosome-associated membrane protein-1 (LAMP-1) and LAMP-2
markedly decreased in Creg1+/− hearts, as did the mature form of ca-
thepsin D (Fig. 5A and B). Meanwhile, immunoﬂuorescence staining
showed that co-localization of cathepsin D and LAMP-1 decreased in
Creg1+/− hearts, which suggested that perinuclear lysosome aggregat-
ed impairment in Creg1+/− hearts (Fig. 5C). These results implied that
CREG1 deﬁciency might be blocking the maturation of lysosome in
Creg1+/− hearts. Because lysosome maturation played a pivotal role in
autophagy, thereby, we deduced that CREG1 deﬁciency induced the
reduction of LAMP-1 and LAMP-2, which might have mediated the
dysfunction of autophagy in Creg1+/− hearts. However, Western
blotting identiﬁed that LAMP-1, LAMP-2 and cathepsin D increased
strikingly in Creg1+/− hearts compared with Creg1+/+ mice hearts
after 3 days with Ang II (Fig. 5D and E). Furthermore, transmission
electron microscopy analysis also identiﬁed that lysosomal structure
and autophagosome–lysosome fusion structure reduced signiﬁcantly
in the Creg1+/− hearts in contrast to Creg1+/+ hearts (Fig. 5F). It is
implicated that a deﬁciency of CREG1 inhibits maturation of lysosome,
but does not directly decrease the expression of its marker proteins.
To explore the mechanisms of CREG1 on lysosome formation,
we monitored the process of lysosome biogenesis from early to late
endosome by measuring Rab1a, Rab5a, Rab7 and Rab9 expression, and
found a signiﬁcant upregulation of Rab1a, Rab5a and Rab9, and a
marked downregulation of Rab7 in Creg1+/−mouse hearts compared
with Creg1+/+ controls (Fig. 5G and H). Meanwhile, immunoﬂuores-
cence staining also identiﬁed that Rab7 expression was reduced in
Creg1+/− hearts (Fig. 5I). More important, Rab7 expression was mark-
edly downregulated in Creg1+/− hearts when it was stimulated byFig. 4. Recombinant CREG1 protein infusion reverses Ang II-induced myocardial ﬁbrosis via act
cardiac ﬁbrosis decrease in 2-month-old Creg1+/−mice hearts with recombinant CREG1 (
heart. Bars = 50 μm. B: Representative images ofWestern blot analyses of CREG1, LC3II/I, Beclin 1
and reCREG1 protein infusion,β-actinwas probed for loading control. C: A summary of densitome
byAng IIwith orwithout reCREG1protein infusion. D and E:Using different concentrations of chlo
expression, β-actin was probed for loading control. F: Masson staining showed cardiac ﬁbrosis
chloroquine (5 or 10 mg/kg · day) infusion for 14 days. Bars = 50 μm. #p b 0.05, **p b 0.01 andAng II (Fig. 5D and E). It is suggested that Rab7 might be an important
molecule downstream of CREG1, which is involved in CREG1-induced
heart autophagy.
3.5. CREG1 activates autophagy in primary cardiomyocytes by modulating
Rab7 expression
To explore the mechanism of CREG1 on myocardiac autophagy, we
overexpressed CREG1 using an adenovirus vector or silenced CREG1
by siRNA in primary cultured cardiomyocytes (CMs), respectively.
CREG1 expression was monitored by immunoblotting and RT-PCR as
shown in Fig. 6A to D. Resveratrol (10 μmol/L), markedly increased
LC3II/I and Beclin-1 expression both in CREG1-ovexpressed and
CREG1-silenced CMs. However, increased p62 was only observed in
CREG1-silenced CMs, but not in CREG1-ovexpressed cells (Fig. 6E and
F). Furthermore, transmission electron microscopy analysis also re-
vealed excessive of autophagic vacuoles in CREG1-silented CMs
compared with that in CREG1-overexpressed cells (Fig. 6G).These re-
sults were consistentwith in vivo data suggesting that CREG1 deﬁciency
inhibits resveratrol-induced autophagy in CMs. In addition, Western
blotting and immunoﬂuorescence staining revealed that knockdown
of CREG1 is sufﬁcient to diminish the expression of Rab7, while overex-
pression of CREG1 increases Rab7 expression in CMs (Fig. 7A and B).
However, RT-PCR revealed that CREG1 did not modulate the expression
of Rab7 in the mRNA level (data not shown). Furthermore, mouse Rab7
siRNAduplexes (Ambion, CA, USA)were used to inhibit the endogenous
Rab7 expression in CMs. As shown in Fig. 7C and D, 80% of Rab7 was
abolished in siRab7-2 and siRab7-3 transfected CMs after 72 hours of
transfection. As expected, resveratrol-induced autophagy in CREG1
overexpressed CMs was signiﬁcantly inhibited in siRab7-transfected
cells compared with that in scramble siRNA transfected cells (Fig. 7E
and F). This result suggested that Rab7 might be involved in the
autophagy of cardiomyocytes mediated by CREG1.
4. Discussion
An important ﬁnding in our study is that CREG1 is a positive contrib-
utor to myocardial autophagy, which prevents cardiomyocyte damage
induced by aging or stress. This beneﬁcial effect can be explained as
follows: (a) CREG1 haploinsufﬁciency is capable of inducing a robust
accumulation of autophagosomes in mice heart cells, and leads to myo-
cardial ﬁbrosis; (b) enhancing CREG1 function with infusion of recom-
binant CREG1 protein completely halts the progression of myocardial
ﬁbrogenesis by rapidly activating autophagy; (c) CREG1-induced in-
crease of Rab7 expression might be a required molecular element that
regulates the cardiac autophagic response to protect cardiomyocytes
from damage.
Autophagy is a conserved catabolic process that is essential for
maintaining cellular homeostasis,which is a critical survivalmechanism
in cells subjected to stress that preserves the cellular energy status
and degrades damaged proteins and organelles [21–24]. A basal level
of autophagy is particularly vital in cardiomyocytes, as these cells are
normally terminally differentiated and cannot decrease toxic concentra-
tions of waste by cell division [9]. Recently, cardiac autophagy was
reported in models of short-term nutrient deprivation [25], chronic
ischemia [26,27] and ischemia-reperfusion injury [28,29]. However,
the mechanisms promoting autophagy in cardiomyocytes are not fully
understood.ivating autophagy in Creg1+/− hearts. A: HE and Masson staining showed Ang II-induced
0.03, 0.06, 0.3 mg/kg · day) infusion compared with Creg1+/−mice or Creg1+/+ mice
andp62 in 2-month-old Creg1+/−mice hearts and age-matchedCreg1+/+micewith Ang II
try data of CREG1, LC3II/I, Beclin 1 and p62 in 2-month-old Creg1+/−mice hearts stimulated
roquine (5 or 10mg/kg · day) blockage for 24 hours,Western blot of p62, Beclin1 and LC3II/I
in 2-month-old Creg1+/−mice hearts with Ang II, reCREG1 protein (0.3 mg/kg · day) and
***p b 0.001.
Fig. 5. Deﬁciency of CREG1 impairs the maturity of lysosome and reduces the expression of Rab7 in Creg1+/−mice heart. A and B: Representative image of Western blot analyses and a
summary of densitometry data for LAMP-1, LAMP-2 and cathepsin D, in 2-month-old Creg1+/−mice hearts and age-matched Creg1+/+ mice, β-actin was probed for loading control.
C: Immunoﬂuorescence staining showed co-localization of cathepsin D and LAMP-1 in 2-month-old Creg1+/−mice hearts and age-matched Creg1+/+ mice. D and E: Representative
image of Western blot analyses and a summary of densitometry data for LAMP-1, LAMP-2, and cathepsin D in 2-month-old Creg1+/− mice heart and age-matched Creg1+/+ mice
with Ang II treatment, β-actin was probed for loading control. F: Electron micrographs of myocardium from Creg1+/+ and Creg1+/− hearts with or without Ang II treatment (bars = 2
μm). Abundant autophagolysosome (white arrow) containing degenerating mitochondria and other cytoplasmic contents are evident in Creg1+/+ hearts compared with accumulation
of autophagosomes (red arrow) in Creg1+/− hearts. G and H: Representative image of Western blot analyses and a summary of densitometry data for Rab7, Rab9, Rab5a and Rab1a in
2-month-old Creg1+/−mice hearts and age-matched Creg1+/+ mice, β-actin was probed for loading control. I: Immunoﬂuorescence staining showed Rab7 in 2-month-old Creg1+/−
mice hearts and age-matched Creg1+/+mice. J and K: Representative image ofWestern blot analyses and a summary of densitometry data for Rab7 in 2-month-old Creg1+/−mice hearts
and age-matched Creg1+/+ mice with Ang II treatment, β-actin was probed for loading control; bars = 100 μm. #p b 0.05, **p b 0.01 and ***p b 0.001.
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molecular, CREG1, promotes cardiomyocyte autophagy during
aging or Ang II-induced damage. First, in a mouse model of CREG1
haploinsufﬁciency, we identiﬁed that CREG1 deﬁciency aggravatesmyo-
cardial damage in response to aging or Ang II. Strikingly, overexpressionof CREG1 by infusion of recombinant exogenous CREG1 completely
reversed cardiac damage and resulted in normal cardiac morphology
and function. This was consistent with previous studies [14,15], which
implied that CREG1 plays an important role in modulating homeosta-
sis in cardiomyocytes. Second, our data showed that both CREG1
Fig. 6. CREG1 overexpression activates autophagy in primary cardiomyocytes (CMs). A and B: Representative images of Western blot analyses of CREG1 and a summary of densitometry
data in CREG1-overexpressed cardiomyocytes (AdCreg1) or in CREG1-silent CMs (siCreg1-1, siCreg1-2 and siCreg1-3). C and D: Representative RT-PCR analyses of CREG1 and a summary
of densitometry data in CREG1-overexpressed cardiomyocytes (AdCreg1) or in CREG1-silent CMs (siCreg1-1, siCreg1-2 and siCreg1-3). E and F: Representative images of Western blot
analyses of LC3II/I, Beclin 1 and p62, and a summary of densitometry data in CREG1-overexpressed cardiomyocytes or in CREG1-silent CMs treated by resveratrol (10 μmol/L) for
24 hours; G: Transmission electronmicrographs showed autophagosomes (red arrow) and autophagolysosome (white arrow) containing degeneratingmitochondria and other cytoplas-
mic contents are evident in CREG1 overexpressed CMs compared with accumulation of autophagosomes in CREG1-silent CMs stimulated by resveratrol (10 μmol/L) for 24 hours. Bars=
0.5 μm. #p b 0.05, **p b 0.01 and ***p b 0.001.
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tion of autophagosomes that acquired LC3II/I and beclin-1 in hearts
with Ang II stimulation. Autophagy is a dynamic process, which begins
with the formation of the double-membrane autophagosome that
engulfs a part of the cytoplasm. Subsequently, the outer membrane of
the autophagosome fuses with late endosomes and lysosomes to
become an autolysosome, and the contents are ﬁnally degraded for
the synthesis of new molecules and organelles [23,24]. Therefore, it is
established that the initial step of autophagic maturation took place in
the hearts of both CREG1-deﬁcient and overexpressed mice. Dramati-
cally, CREG1 deﬁciency-induced vacuolation did not reﬂect reduced
but rather enhanced expression of p62, an adaptor protein that gets
consumed during autophagy [30,31], which suggested that the aberrant
accumulation of enlarged hybrid compartments was due to delayed/
arrested autolysosomal maturation in Creg1+/− mice. However,overexpression of CREG1 resulted promptly in the degradation of p62,
implying that autophagy occurred rapidly. Therefore, we deduced that
the large capacity of autophagosomes inducedbyCREG1 allows autoph-
agy to remove damaged organelles and protein aggregates to maintain
organelle function and protein quality, while suppression of CREG1
below physiological levels might induce heart damage with enhanced
protein aggregation. To conﬁrm this, we blocked autophagy ﬂux using
chloroquine, which is known to inhibit lysosomal acidiﬁcation [32],
and investigated the levels of Beclin-1, LC3II/I and p62 increased in
chloroquine-treated cardiomyocytes, accompanied by further exagger-
ation of the ﬁbrosis response, ignoring the effects of CREG1 on
myocardiac protection. The result suggested that CREG1-induced au-
tophagy is required to withstand Ang II-induced myocardial ﬁbrosis,
and CREG1 is a critical mediator of autophagy activation andmodulator
of physiological or pathological cardiomyocyte stress. This novel protein
Fig. 7. CREG1-regulated Rab7 expression involved in CMs autophagy. A and B: Representative Rab7 and a summary of densitometry data in CREG1-overexpressed or CREG1-silent CMs C:
Immunoﬂuorescence staining showed localization of Rab7 in CREG1-overexpressed or CREG1-silent cells. Bars=100 μm.D and E: Representative images ofWestern blot analyses of Rab7
and a summary of densitometry data inRab7-silent CMs. F andG: Representative images ofWestern blot analyses of LC3II/I, Beclin 1 and p62, and a summary of densitometry data inRab7-
silent CMs treated by resveratrol (10 μmol/L) and Ad-CREG1 for 24 hours; #p b 0.05, **p b 0.01 and ***p b 0.001.
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be used to study the effect of rapid autophagy in a stressed organ
system.
Another contribution of this study is the conﬁrmation of an impor-
tant role of CREG1 in activating Rab7 expression in the cardiomyocytes.
Here, we found the coexistence of increased autophagosomes with de-
creased autophagic ﬂux both in adult Creg1+/− mouse hearts and
with CREG1-ablated primary cultured cardiomyocytes, conﬁrming that
CREG1 is required for autophagosome–lysosome formation. Impaired
autophagosome–lysosomes formation can result from defective fusion
between autophagosome with lysosome, or lysosome malfunction
[33,34]. Therefore, we further investigated the impact of CREG1 deﬁ-
ciency on the function of lysosome. Both in vitro and in vivo studiesidentiﬁed that CREG1 deﬁciency reduced the lysosome maturation
and the formation of autophagolysosomes accompanied by a reduction
of Rab7.
Rab proteins are a family of small molecular weight guanine nucleo-
tide-binding proteins (G-proteins) that regulate vesicular budding and
fusion reactions by oscillating between active (GTP-bound) and inactive
(GDP-bound) forms [35,36]. Over 60 different Rab proteins have been
identiﬁed, and each is unique in cellular and subcellular localization,
as well as the vesicles that it fuses [37]. There are studies indicating
that Rab5 and Rab1 have a role in mediating the fusion of the early en-
dosome [38], Rab11 in facilitating recycling endosomes [39] and Rab7
and Rab9 in regulating late endosome fusion with lysosomes [40].
Rab7 is a 23-kDa protein that is localized to late endosome, which in
363C. Yan et al. / Biochimica et Biophysica Acta 1852 (2015) 353–364particular has been suggested to regulate the transport from early to
late endosomes that is essential for the maintenance of a functional
lysosome compartment but not for the function of earlier endocytic
compartments [41–44]. In the present study, CREG1 deﬁciency resulted
in the absence of functional Rab7 protein, which might be directly
involved in the aggregation and fusion of late endocytic structures/
lysosomes and accumulation of autophagosomes. Although the
mechanism by which CREG1 modulating Rab7 expression is not
clear, the present study conﬁrmed that downregulation of Rab7
had a negative effect on CREG1-induced autophagic vacuole matura-
tion, implying that Rab7 is a nexus through which CREG1 regulates
autophagolysosome maturation to activate autophagy. Certainly, more
detailed studies will be done in Rab7 knockout mouse to conﬁrm the
biofunction of Rab7 mediated by CREG1.
Taken together, CREG1 is indispensable to cardiomyocyte survival
via keeping its autophagy homeostasis, not only in physiologic heart
stress but also in pathological heart stress. Thismay provide a therapeu-
tic target to reduce myocardial damage, particularly in patients with
heart remodeling and heart failure.
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